Operating an unlicensed private Positron Emission Tomography (PET) radiopharmacy in Nigeria attracts severe statutory penalties including criminal prosecution, mandatory facility sealing, forfeiture of radioactive materials, and heavy fines under the Nuclear Safety and Radiation Protection Act and the Pharmacy Council of Nigeria Act. Unlawful handling of cyclotron-produced radioisotopes exposes facility directors and technical managers to up to five years imprisonment alongside summary administrative closure by the Nigerian Nuclear Regulatory Authority (NNRA).
Positron Emission Tomography utilizes short-lived positron-emitting radionuclides such as Fluorine-18, Carbon-11, and Gallium-68 synthesized into specialized radiopharmaceuticals for molecular cancer diagnostics. Because these clinical substances involve ionizing radiation hazards alongside sterile injectable production standards, federal authorities enforce strict multi-agency oversight across nuclear, pharmaceutical, and environmental jurisdictions.
Statutory Penalties Under the Nuclear Safety and Radiation Protection Act
The Nuclear Safety and Radiation Protection Act 1995 (Cap N142 LFN 2004) empowers the Nigerian Nuclear Regulatory Authority to control, supervise, and license all facilities housing ionizing radiation sources, particle accelerators, and medical cyclotrons.
- Imprisonment and Heavy Corporate Fines: Under Section 43 and Section 44 of the Act, any entity or corporate officer that installs a cyclotron, produces radionuclides, or operates a radiopharmacy without an NNRA license commits a serious federal offense carrying terms of imprisonment up to five years, statutory fines, or both.
- Confiscation of Ionizing Radiation Sources: The NNRA possesses statutory powers to seize, impound, and securely decommission all unauthorized radiation generators, hot cells, synthesis modules, and radioactive source materials at the operator expense.
- Summary Sealing of Premises: Federal nuclear inspectors, accompanied by security personnel, are legally empowered to shut down and seal off unlicensed radiation facilities without prior notice to avert public contamination risks.
- Personal Liability for Corporate Directors: Under Section 45, where an offense is committed by a body corporate, every director, manager, and secretary is deemed personally guilty unless they establish that the offense took place without their knowledge and consent.
Sanctions Under the Pharmacy Council of Nigeria (PCN) Act 2022
A PET radiopharmacy qualifies as a specialized pharmaceutical manufacturing and compounding facility. Operating without a valid premises license issued by the Pharmacy Council of Nigeria invokes severe statutory sanctions under Section 53 and Section 54 of the PCN Act 2022.
- Operating an Unregistered Premises: The PCN enforcement directorate enforces fines ranging from two million five hundred thousand Naira to five million Naira for running an uncertified drug preparation facility.
- Absence of a Registered Radiopharmacist: Every radiopharmacy must maintain a superintendent pharmacist holding specialized postgraduate qualification or certified competence in radiopharmacy. Employing unqualified individuals to compound radiotracers triggers immediate license revocation and professional disbarment of collaborating practitioners.
- Permanent Closure and Prosecution: The PCN can institute direct criminal proceedings at the Federal High Court against facility operators for illicit compounding, distribution, and commercial dispensing of unregistered sterile radiopharmaceuticals.
NAFDAC and NESREA Regulatory Penalties
The National Agency for Food and Drug Administration and Control classifies radiopharmaceuticals as high-risk prescription-only medicines. Compounding, importing cold kits, or distributing radiotracers without NAFDAC product registration violates the Counterfeit and Fake Drugs and Unwholesome Processed Foods (Miscellaneous Provisions) Act, attracting fines of up to five hundred thousand Naira and imprisonment for not less than five years without the option of a fine.
Furthermore, under the National Environmental Standards and Regulations Enforcement Agency (NESREA) Act, improper disposal of radioactive medical waste or volatile radioactive exhaust gases from hot cell ventilation channels exposes the facility to environmental remediation fines exceeding ten million Naira and corporate restitution orders.
Mandatory Steps to Lawfully Establish a PET Radiopharmacy
- Incorporate with Corporate Affairs Commission: Register a specialized private limited liability company with an authorized share capital of at least twenty million Naira to satisfy heavy medical equipment procurement requirements.
- Obtain NNRA Siting and Construction Approvals: Secure NNRA authorization for facility siting, biological bunker shielding design, cyclotron vault construction, and radiation safety officer appointment.
- Procure PCN Premises Registration: File formal architectural drawings, sterile cleanroom specifications (ISO Class 5 hot cells within ISO Class 7 cleanrooms), and retain a licensed superintendent radiopharmacist.
- Complete NAFDAC Good Radiopharmacy Practice Audit: Pass quality assurance inspections covering automated synthesizer validation, pyrogen testing, radio-TLC purity analysis, and sterile vial dispensing controls before releasing any radiopharmaceutical batch for clinical use.



